You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, August 24, 2016 - 12:00
Condition:   Neonatal Hypoxic-ischaemic Encephalopathy
Intervention:   Drug: autologous cord blood stem cell
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Wednesday, August 10, 2016 - 12:00
Conditions:   Congestive Heart Failure;   Heart Failure, Diastolic
Interventions:   Biological: Allogenic Derived Cells;   Biological: Placebo/Control Arm
Sponsor:   Medical University of South Carolina
Recruiting - verified August 2016
Posted: Sunday, August 7, 2016 - 12:00
Condition:   Coronary Artery Disease
Intervention:   Biological: Transepicardial with Transseptal CD 133+ Implantation
Sponsor:   National Cardiovascular Center Harapan Kita Hospital Indonesia
Recruiting - verified August 2016
Posted: Friday, August 5, 2016 - 12:00
Condition:   Diabetic Foot Ulcer
Intervention:   Drug: adipose-derived regenerative cells (ADRCs)
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Tuesday, August 2, 2016 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: [18F] FES
Sponsor:   University of Pennsylvania
Recruiting - verified September 2016
Posted: Monday, July 25, 2016 - 12:00
Condition:   Abdominal Aortic Aneurysm
Intervention:   Biological: MSC's or Plasmalyte
Sponsor:   VA Office of Research and Development
Not yet recruiting - verified July 2016
Posted: Saturday, July 9, 2016 - 12:00
Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: Adipose-derived stem cell;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016
Posted: Saturday, July 9, 2016 - 12:00
Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: Umbilical Cord Mesenchymal Stem Cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016
Posted: Wednesday, July 6, 2016 - 12:00
Condition:   Stroke
Interventions:   Other: Adipose Derived Stem Cells;   Other: Vehicle media
Sponsors:   University Hospital, Grenoble;   European Commission H2020 program;   Univ Grenoble Alpes, France;   Servicio Madrileño de Salud, Madrid, Spain;   Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic;   Servicio Andaluz de Salud, Spain;   University of Glasgow;   University of Eastern Finland;   Etablissement Français du Sang;   University of Tampere;   Histocell SL, Spain;   Medfiles CRO, Finland;   Institut National de la Santé Et de la Recherche Médicale, France;   Hospices Civils de Lyon;   Association groupe ESSEC, France;   NOVADISCOVERY SAS, France;   FINOVATIS, France;   CHU Besancon, France;   Assistance Publique - Hôpitaux de Paris;   CHU Toulouse, France;   CHU Bordeaux, France;   CHU Cote de Nacre, Caen, France;   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Servicio de Salud de Castilla La Mancha, Albacete, Spain;   Servizo Galego de Saude, Santiago de Compostela, Spain;   Pirkanmaa Hospital District, Tampere, Finland;   Hospital Vall d'Hebron;   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Posted: Friday, June 17, 2016 - 12:00
Condition:   Chronic Ischemic Heart Disease
Intervention:   Drug: Bone Marrow Derived Autologous CD133+ Selected Cell Product
Sponsor:   Michael Sekela
Recruiting - verified February 2017

Pages